We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.8%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$83B
AUM Growth
+$4.08B
(+5.2%)
Cap. Flow
-$2.07B
Cap. Flow
% of AUM
-2.5%
Top 10 Holdings %
Top 10 Hldgs %
13.18%
Holding
730
New
59
Increased
161
Reduced
398
Closed
45
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keurig Dr Pepper
KDP
|
+$550M |
| 2 |
Fidelity National Information Services
FIS
|
+$353M |
| 3 |
Global Payments
GPN
|
+$263M |
| 4 |
CVS Health
CVS
|
+$175M |
| 5 |
Devon Energy
DVN
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$433M |
| 2 |
Lowe's Companies
LOW
|
+$277M |
| 3 |
Oracle
ORCL
|
+$226M |
| 4 |
Progressive
PGR
|
+$220M |
| 5 |
Las Vegas Sands
LVS
|
+$167M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.96% |
| 2 | Healthcare | 15.3% |
| 3 | Industrials | 15.12% |
| 4 | Technology | 14.91% |
| 5 | Consumer Discretionary | 11.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Landstar System
LSTR
$6.5B
| $63.1M | 0.08% |
352,804
-16,157
| -4% | -$2.77M |
|
227
LCI Industries
LCII
$2.52B
| $61.5M | 0.07% |
394,216
-2,578
| -0.6% | -$383K |
|
228
NCR Voyix
VYX
$1.13B
| $61M | 0.07% |
2,459,223
-29,220
| -1% | -$741K |
|
229
Amdocs
DOX
$5.64B
| $60.9M | 0.07% |
813,274
-49,643
| -6% | -$3.73M |
|
230
PACCAR
PCAR
$70.2B
| $60.6M | 0.07% |
1,030,400
-61,069
| -6% | -$3.53M |
|
|
OCDX
231
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $59.7M | 0.07% |
2,809,591
-30,176
| -1% | -$595K |
|
232
TD Synnex
SNX
$19.6B
| $58.1M | 0.07% |
508,325
-136,774
| -21% | -$14.9M |
|
233
AXIS Capital
AXS
$8.63B
| $57.1M | 0.07% |
1,045,429
-327,026
| -24% | -$16.9M |
|
234
Energizer
ENR
$1.44B
| $56.1M | 0.07% |
1,398,059
-12,437
| -0.9% | -$478K |
|
235
Steven Madden
SHOO
$3.18B
| $54.3M | 0.07% |
1,170,553
-8,432
| -0.7% | -$388K |
|
236
First Hawaiian
FHB
$3.38B
| $53.4M | 0.06% |
1,928,216
-12,618
| -0.7% | -$352K |
|
237
Markel Group
MKL
$25.2B
| $53.1M | 0.06% |
43,068
-2,541
| -6% | -$3.21M |
|
238
World Kinect Corp
WKC
$2.04B
| $52.7M | 0.06% |
1,966,530
-227,693
| -10% | -$6.5M |
|
|
OPLN
239
Openlane
OPLN
$4.25B
| $52.5M | 0.06% |
3,341,940
-1,231,797
| -27% | -$18.9M |
|
240
InterDigital
IDCC
$6.7B
| $50.3M | 0.06% |
704,215
-30,574
| -4% | -$2.13M |
|
241
Bankunited
BKU
$3.36B
| $49.5M | 0.06% |
1,158,494
-9,402
| -0.8% | -$394K |
|
242
Navient
NAVI
$809M
| $48.5M | 0.06% |
2,275,241
-1,562,204
| -41% | -$31.6M |
|
|
UCTT
243
Ultra Clean Holdings
UCTT
$3.9B
| $46.6M | 0.06% |
812,187
-9,657
| -1% | -$502K |
|
|
SNV
244
DELISTED
Synovus
SNV
| $46.2M | 0.06% |
951,068
-6,255
| -0.7% | -$296K |
|
245
Analog Devices
ADI
$181B
| $46.1M | 0.06% |
262,532
-15,456
| -6% | -$2.74M |
|
246
Huron Consulting
HURN
$1.89B
| $45.5M | 0.05% |
912,478
-137,002
| -13% | -$6.84M |
|
247
Hanover Insurance
THG
$7.68B
| $44.5M | 0.05% |
338,019
-2,061
| -0.6% | -$267K |
|
248
Spectrum Brands
SPB
$2.04B
| $44.1M | 0.05% |
433,083
-39,386
| -8% | -$3.87M |
|
249
Brink's
BCO
$4.86B
| $43.8M | 0.05% |
667,301
+298,393
| +81% | +$19.2M |
|
|
ERF
250
DELISTED
Enerplus Corporation
ERF
| $43.3M | 0.05% |
3,981,641
-345,207
| -8% | -$3.35M |
|
Similar funds
Boston Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Boston Partners held 730 positions worth $83B, up 5.2% from $78.9B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Boston Partners's Q4 2021 filing shows 59 new, 161 increased, 398 reduced and 45 closed positions. Its largest new stake was Keurig Dr Pepper: 15,605,496 shares worth $575M. The largest sale was Pfizer, an estimated $433M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Industrials.
- Boston Partners's largest Q4 2021 buy was Keurig Dr Pepper: 15,605,496 shares worth $575M.
- Boston Partners added most to Fidelity National Information Services in Q4 2021, an estimated $353M increase.
- Boston Partners's biggest Q4 2021 reduction was Pfizer, cutting an estimated $433M.
- Boston Partners fully exited CyrusOne Inc Common Stock in Q4 2021, selling an estimated $137M.
- Boston Partners's ten largest holdings make up 13% of its $83B portfolio in Q4 2021.
- Boston Partners opened 59 new positions and closed 45 in Q4 2021.
- Boston Partners's portfolio value rose 5.2% quarter-over-quarter to $83B.
Based on Boston Partners's 13F filing for Q4 2021, filed 4 Feb 2022.